Marksans Pharma is currently trading at Rs. 48.50, up by 7.90 points or 19.46% from its previous closing of Rs. 40.60 on the BSE.
The scrip opened at Rs. 41.65 and has touched a high and low of Rs. 48.70 and Rs. 41.65 respectively. So far 9089744 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 58.30 on 06-Oct-2016 and a 52 week low of Rs. 33.45 on 01-Mar-2016.
Last one week high and low of the scrip stood at Rs. 48.70 and Rs. 37.10 respectively. The current market cap of the company is Rs. 1983.12 crore.
The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 14.54% and 37.21% respectively.
Marksans Pharma's Goa plant has had an inspection by UK MHRA from February 14, 2017 to February 17, 2017 and it is located at L-82 & L-83, Verna Industrial Estate in Goa. The same has been completed without any critical observations. The company is awaiting further instruction from the agency in this regard.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.